Silver Creek Pharmaceuticals

South San Francisco, CA · Founded 2010 · Privately Held (backing)

Operator of a biotechnology firm intended to develop therapies that improve the body's healing response and repair damaged tissue. Silver Creek Pharmaceuticals is based in South San Francisco, CA and was founded in 2010. Its last reported valuation was $60 million in Feb 2018. It has raised $57.1 million across 2 recorded rounds; the latest was a $9.2 million early-stage round in Jan 2022.

Last reported valuation
$60.0M
Oct 2026
Priced at
—
Total raised
$57.1M
Last round
Early Stage VC
Jan 2022
What is Silver Creek Pharmaceuticals worth?
$60.0Mlast reported valuation · Oct 2026

Silver Creek Pharmaceuticals's last reported valuation, Feb 2018. Nothing priced has surfaced since.

Free account
More of Silver Creek Pharmaceuticals with a free account
  • ·Watch Silver Creek Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Silver Creek Pharmaceuticals funding history

2 rounds
DateRoundRaisedPost-money
Jan 2022Early Stage VC$9.2M▮
Dec 2016Seed Round$3.4M▮
Unlock post-money valuations

Membership and data by Private Market View

Silver Creek Pharmaceuticals valuation

Silver Creek Pharmaceuticals's last reported valuation was $60 million in Feb 2018. No priced round, secondary trade or fund mark has surfaced since.

How much has Silver Creek Pharmaceuticals raised?

Silver Creek Pharmaceuticals has raised $57.1 million in total; 2 of its rounds are on record. The largest on record was a $9.2 million early-stage round in Jan 2022.

Silver Creek Pharmaceuticals has filed 2 Form Ds with the SEC since 2016, most recently in Feb 2022 ($9.2 million sold to 22 investors).

How Silver Creek Pharmaceuticals's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Silver Creek Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Silver Creek Pharmaceuticals

What is Silver Creek Pharmaceuticals worth?
Silver Creek Pharmaceuticals is valued at $60.0M as of Oct 2026. Silver Creek Pharmaceuticals's last reported valuation, Feb 2018. Nothing priced has surfaced since.
How much has Silver Creek Pharmaceuticals raised?
Silver Creek Pharmaceuticals has raised $57.1M in total funding across 2 recorded rounds.
When did Silver Creek Pharmaceuticals last raise?
Silver Creek Pharmaceuticals last raised in Jan 2022 (Early Stage VC), raising $9.2M.